Global Encephalopathy Treatment Market 2019-2023 - Rise in Initiatives to Increase the Awareness About Encephalopathy Disease Management and Effective Treatment of Encephalopathy - ResearchAndMarkets.com

December 6, 2018

DUBLIN--(BUSINESS WIRE)--Dec 6, 2018--The “Global Encephalopathy Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The Global Encephalopathy Treatment Market is projected to grow at a CAGR of 4.75% during the period 2019-2023.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the emergence of novel treatment targets for encephalopathy. Certain candidates are under investigation for the treatment of liver cirrhosis which is one of the leading causes of hepatic encephalopathy.

According to the report, one driver influencing this market is the rise in initiatives to increase the awareness about encephalopathy disease management and effective treatment of encephalopathy. Most of the programs aim at providing co-pay assistance, educational material for hepatic encephalopathy, and treatment adherence support. The growing availability of such patient awareness programs for assistance in the management and treatment of encephalopathy is expected to boost the growth of the global encephalopathy market.

Further, the report states that one challenge affecting this market is the adverse side effects associated with available drugs. The growth of the market is impeded by the adverse side effects such as severe stomach pain, diarrhea, and flatulence due to the available drugs for the treatment of encephalopathy.

Market Trends

Emergence of Novel Treatment Targets for Encephalopathy Increase in FDA Drug Approval for Diseases Associated with Encephalopathy Increase in Adoption of Technological Advances for Treating Encephalopathy

Key Vendor

Bausch Health

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Market Landscape

4. Pipeline Analysis

5. Market Sizing

6. Five Forces Analysis

7. Market Segmentation by Type

8. Customer Landscape

9. Geographic Landscape

10. Decision Framework

11. Drivers and Challenges

12. Market Trends

13. Vendor Landscape

14. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/38lc3q/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181206005764/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/06/2018 12:58 PM/DISC: 12/06/2018 12:58 PM


Update hourly